MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon

NCT07326735 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

Interventions

DEVICE: Mamba Sirolimus-Eluting PTCA Balloon
DEVICE: Percutaneous Coronary Angioplasty with Sirolimus-Coated Balloon

Sponsor

Frisch Medical Device Private Limited